Intrinsic Value

Zynerba Pharmaceuticals, Inc. (ZYNE)

$1.3

+0.03 (+2.36%)

Enterprise Value -
Net Debt -50.31
Equity Value -
Shares Outstanding 42.66
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt